Skip to main content
Top
Published in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie 8/2022

28-02-2022 | Opioids | Reports of Original Investigations

Transcultural validation of a French–European version of the Prescription Opioid Misuse Index Scale (POMI-5F)

Authors: Noémie Delage, MD, PhD, Nathalie Cantagrel, MD, PhD, Jessica Delorme, PhD, Bruno Pereira, PhD, Christian Dualé, MD, PhD, Celian Bertin, MD, PhD, Chouki Chenaf, MD, PhD, Nicolas Kerckhove, PhD, Catherine Laporte, MD, PhD, Pascale Picard, MD, PhD, Anne Roussin, MD, PhD, Nicolas Authier, MD, PharmD, PhD

Published in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Issue 8/2022

Login to get access

Abstract

Purpose

The Prescription Opioid Misuse Index scale (POMI) is a brief questionnaire used to assess opioid prescription misuse. In view of the increase in the prescription of opioid analgesics for chronic noncancer pain (CNCP), this tool is particularly useful during medical consultations to screen opioid misuse in patients using opioids. We sought to generate and validate a French–European translation of the POMI.

Methods

We conducted an observational, longitudinal, and multicenter psychometric study with crosscultural validation. All adult CNCP patients who were treated with opioids for at least three months, were followed in pain clinics, and spoke French were eligible. From September 2015 to November 2017, we included 163 patients and analyzed 154. We performed a pretest on a sample of representative patients to evaluate acceptability and understanding of translation. Study patients completed the POMI scale at a pain clinic (test phase), and we assessed test–retest reliability after two to four weeks by a second completion of the POMI scale at home by patients (retest phase). We subsequently explored psychometric properties of the POMI (acceptability, internal consistency, reproducibility, and external validity).

Results

Due to poor internal consistency and reproducibility, items 4, 7, and 8 of the original POMI scale were removed, and we proposed a five-question French–European version (POMI-5F). The internal consistency of POMI-5F was good (Cronbach’s α = 0.71), as was test–retest reliability (r = 0.65 [0.55–0.67]). The external validity of POMI-5F, compared with the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, was moderate but significant (r = 0.45; P < 0.001). The optimal POMI-5F cut-off score to indicate misuse was 2/5 (sensitivity = 0.95 and specificity = 0.54).

Conclusion

We generated and validated a French–European translation of the POMI scale, POMI-5F, for use by French researchers and physicians to identify opioid misuse in CNCP patients.
Appendix
Available only for authorised users
Literature
1.
go back to reference Chenaf C, Delorme J, Delage N, Ardid D, Eschalier A, Authier N. Prevalence of chronic pain with or without neuropathic characteristics in France using the capture-recapture method: a population-based study. Pain 2018; 159: 2394-402.CrossRef Chenaf C, Delorme J, Delage N, Ardid D, Eschalier A, Authier N. Prevalence of chronic pain with or without neuropathic characteristics in France using the capture-recapture method: a population-based study. Pain 2018; 159: 2394-402.CrossRef
3.
4.
go back to reference Steingrímsdóttir ÓA, Landmark T, Macfarlane GJ, Nielsen CS. Defining chronic pain in epidemiological studies: a systematic review and meta-analysis. Pain 2017; 158: 2092-107.CrossRef Steingrímsdóttir ÓA, Landmark T, Macfarlane GJ, Nielsen CS. Defining chronic pain in epidemiological studies: a systematic review and meta-analysis. Pain 2017; 158: 2092-107.CrossRef
5.
go back to reference Dueñas M, Ojeda B, Salazar A, Mico JA, Failde I. A review of chronic pain impact on patients, their social environment and the health care system. J Pain Res 2016; 9: 457-67.CrossRef Dueñas M, Ojeda B, Salazar A, Mico JA, Failde I. A review of chronic pain impact on patients, their social environment and the health care system. J Pain Res 2016; 9: 457-67.CrossRef
7.
go back to reference Franklin GM; American Academy of Neurology. Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology. Neurology 2014; 83: 1277-84.CrossRef Franklin GM; American Academy of Neurology. Opioids for chronic noncancer pain: a position paper of the American Academy of Neurology. Neurology 2014; 83: 1277-84.CrossRef
8.
go back to reference Manchikanti L, Abdi S, Atluri S, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part I--evidence assessment. Pain Physician 2012; 15(3 Suppl): S1-65.CrossRef Manchikanti L, Abdi S, Atluri S, et al. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: part I--evidence assessment. Pain Physician 2012; 15(3 Suppl): S1-65.CrossRef
9.
go back to reference Nadeau SE. Opioids for chronic noncancer pain: to prescribe or not to prescribe-what is the question? Neurology 2015; 85: 646-51.CrossRef Nadeau SE. Opioids for chronic noncancer pain: to prescribe or not to prescribe-what is the question? Neurology 2015; 85: 646-51.CrossRef
10.
go back to reference Atluri S, Sudarshan G, Manchikanti L. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011. Pain Physician 2014; 17: E119-28.CrossRef Atluri S, Sudarshan G, Manchikanti L. Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011. Pain Physician 2014; 17: E119-28.CrossRef
11.
go back to reference Dart RC, Surratt HL, Cicero TJ, et al, Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med 2015; 372: 241-8.CrossRef Dart RC, Surratt HL, Cicero TJ, et al, Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med 2015; 372: 241-8.CrossRef
12.
go back to reference Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician 2010; 13: 401-35.CrossRef Manchikanti L, Fellows B, Ailinani H, Pampati V. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Pain Physician 2010; 13: 401-35.CrossRef
13.
go back to reference Berterame S, Erthal J, Thomas J, et al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet 2016; 387: 1644-56.CrossRef Berterame S, Erthal J, Thomas J, et al. Use of and barriers to access to opioid analgesics: a worldwide, regional, and national study. Lancet 2016; 387: 1644-56.CrossRef
14.
go back to reference Chenaf C, Kaboré JL, Delorme J, et al. Prescription opioid analgesic use in France: trends and impact on morbidity-mortality. Eur J Pain 2019; 23: 124-34.CrossRef Chenaf C, Kaboré JL, Delorme J, et al. Prescription opioid analgesic use in France: trends and impact on morbidity-mortality. Eur J Pain 2019; 23: 124-34.CrossRef
15.
go back to reference Shipton EA, Shipton EE, Shipton AJ . A review of the opioid epidemic: what do we do about it? Pain Ther 2018; 7: 23-36.CrossRef Shipton EA, Shipton EE, Shipton AJ . A review of the opioid epidemic: what do we do about it? Pain Ther 2018; 7: 23-36.CrossRef
16.
go back to reference Helmerhorst GT, Teunis T, Janssen SJ, Ring D. An epidemic of the use, misuse and overdose of opioids and deaths due to overdose, in the United States and Canada: is Europe next? Bone Joint J 2017; 99-B: 856-64. Helmerhorst GT, Teunis T, Janssen SJ, Ring D. An epidemic of the use, misuse and overdose of opioids and deaths due to overdose, in the United States and Canada: is Europe next? Bone Joint J 2017; 99-B: 856-64.
21.
go back to reference Compton WM, Boyle M, Wargo E. Prescription opioid abuse: problems and responses. Prev Med 2015; 80: 5-9.CrossRef Compton WM, Boyle M, Wargo E. Prescription opioid abuse: problems and responses. Prev Med 2015; 80: 5-9.CrossRef
22.
go back to reference Chenaf C, Kabore JL, Delorme J, et al. Codeine shopping behavior in a retrospective cohort of chronic noncancer pain patients: incidence and risk factors. J Pain 2016; 17: 1291-301.CrossRef Chenaf C, Kabore JL, Delorme J, et al. Codeine shopping behavior in a retrospective cohort of chronic noncancer pain patients: incidence and risk factors. J Pain 2016; 17: 1291-301.CrossRef
23.
go back to reference Chenaf C, Kabore JL, Delorme J, et al. Incidence of tramadol shopping behavior in a retrospective cohort of chronic non-cancer pain patients in France. Pharmacoepidemiol Drug Saf 2016; 25: 1088-98.CrossRef Chenaf C, Kabore JL, Delorme J, et al. Incidence of tramadol shopping behavior in a retrospective cohort of chronic non-cancer pain patients in France. Pharmacoepidemiol Drug Saf 2016; 25: 1088-98.CrossRef
24.
go back to reference Kaye AD, Jones MR, Kaye AM, et al. Prescription opioid abuse in chronic pain: An updated review of opioid abuse predictors and strategies to curb opioid abuse (part 2). Pain Physician 2017; 20: S111-33.PubMed Kaye AD, Jones MR, Kaye AM, et al. Prescription opioid abuse in chronic pain: An updated review of opioid abuse predictors and strategies to curb opioid abuse (part 2). Pain Physician 2017; 20: S111-33.PubMed
25.
go back to reference Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the current opioid misuse measure. Pain 2007; 130: 144-56.CrossRef Butler SF, Budman SH, Fernandez KC, et al. Development and validation of the current opioid misuse measure. Pain 2007; 130: 144-56.CrossRef
26.
go back to reference Knisely JS, Wunsch MJ, Cropsey KL, Campbell ED. Prescription Opioid Misuse Index: a brief questionnaire to assess misuse. J Subst Abuse Treat 2008; 35: 380-6.CrossRef Knisely JS, Wunsch MJ, Cropsey KL, Campbell ED. Prescription Opioid Misuse Index: a brief questionnaire to assess misuse. J Subst Abuse Treat 2008; 35: 380-6.CrossRef
27.
go back to reference Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993; 46: 1417-32.CrossRef Guillemin F, Bombardier C, Beaton D. Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines. J Clin Epidemiol 1993; 46: 1417-32.CrossRef
28.
go back to reference Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 2000; 25: 3186-91. Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine (Phila Pa 1976) 2000; 25: 3186-91.
30.
go back to reference Vetter TR, Cubbin C. Psychometrics: trust, but verify. Anesth Analg 2019; 128: 176-81.CrossRef Vetter TR, Cubbin C. Psychometrics: trust, but verify. Anesth Analg 2019; 128: 176-81.CrossRef
31.
go back to reference Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res 2010; 19: 539-49.CrossRef Mokkink LB, Terwee CB, Patrick DL, et al. The COSMIN checklist for assessing the methodological quality of studies on measurement properties of health status measurement instruments: an international Delphi study. Qual Life Res 2010; 19: 539-49.CrossRef
32.
go back to reference Terwee CB, Mokkink LB, Knol DL, Ostelo RW, Bouter LM, de Vet HC. Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res 2012; 21: 651-7.CrossRef Terwee CB, Mokkink LB, Knol DL, Ostelo RW, Bouter LM, de Vet HC. Rating the methodological quality in systematic reviews of studies on measurement properties: a scoring system for the COSMIN checklist. Qual Life Res 2012; 21: 651-7.CrossRef
33.
go back to reference Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007; 60: 34-42.CrossRef Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007; 60: 34-42.CrossRef
36.
go back to reference Moisset X, Martinez V. Opioid use for the management of chronic non-cancer pain: French guidelines. Rev Neurol (Paris) 2016; 172: 337-8.CrossRef Moisset X, Martinez V. Opioid use for the management of chronic non-cancer pain: French guidelines. Rev Neurol (Paris) 2016; 172: 337-8.CrossRef
37.
go back to reference Højsted J, Sjøgren P. Addiction to opioids in chronic pain patients: a literature review. Eur J Pain 2007; 11: 490-518.CrossRef Højsted J, Sjøgren P. Addiction to opioids in chronic pain patients: a literature review. Eur J Pain 2007; 11: 490-518.CrossRef
38.
go back to reference Latkin CA, Edwards C, Davey-Rothwell MA, Tobin KE. The relationship between social desirability bias and self-reports of health, substance use, and social network factors among urban substance users in Baltimore, Maryland. Addict Behav 2017; 73: 133-6.CrossRef Latkin CA, Edwards C, Davey-Rothwell MA, Tobin KE. The relationship between social desirability bias and self-reports of health, substance use, and social network factors among urban substance users in Baltimore, Maryland. Addict Behav 2017; 73: 133-6.CrossRef
39.
go back to reference Tompkins DA, Huhn AS, Johnson PS, et al. To take or not to take: the association between perceived addiction risk, expected analgesic response and likelihood of trying novel pain relievers in self-identified chronic pain patients. Addiction 2018; 113: 67-79.CrossRef Tompkins DA, Huhn AS, Johnson PS, et al. To take or not to take: the association between perceived addiction risk, expected analgesic response and likelihood of trying novel pain relievers in self-identified chronic pain patients. Addiction 2018; 113: 67-79.CrossRef
40.
go back to reference McHugh RK, Weiss RD, Cornelius M, Martel MO, Jamison RN, Edwards RR. Distress intolerance and prescription opioid misuse among patients with chronic pain. J Pain 2016; 17: 806-14.CrossRef McHugh RK, Weiss RD, Cornelius M, Martel MO, Jamison RN, Edwards RR. Distress intolerance and prescription opioid misuse among patients with chronic pain. J Pain 2016; 17: 806-14.CrossRef
Metadata
Title
Transcultural validation of a French–European version of the Prescription Opioid Misuse Index Scale (POMI-5F)
Authors
Noémie Delage, MD, PhD
Nathalie Cantagrel, MD, PhD
Jessica Delorme, PhD
Bruno Pereira, PhD
Christian Dualé, MD, PhD
Celian Bertin, MD, PhD
Chouki Chenaf, MD, PhD
Nicolas Kerckhove, PhD
Catherine Laporte, MD, PhD
Pascale Picard, MD, PhD
Anne Roussin, MD, PhD
Nicolas Authier, MD, PharmD, PhD
Publication date
28-02-2022
Publisher
Springer International Publishing
Published in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Issue 8/2022
Print ISSN: 0832-610X
Electronic ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-022-02210-7

Other articles of this Issue 8/2022

Canadian Journal of Anesthesia/Journal canadien d'anesthésie 8/2022 Go to the issue